熱門資訊> 正文
Lucid Diagnostics在定价2500万美元股票发行后股价下跌
2025-09-10 20:29
- Lucid(LCID) 0
- 纳比特(NA) 0
- 盛大科技(SDA) 0
- Lucid Diagnostics (NASDAQ:LUCD) fell over 17% premarket on Wednesday after it priced a public offering of 25 million shares at $1.00 each.
- Underwriters also have a 30-day option to buy up to 3.75 million additional shares at the same price, excluding fees.
- The gross proceeds from the offering are expected to be approximately $25.0 million. The company intends to use the net proceeds from this offering for working capital and general corporate purposes.
- The offering is expected to close on or about September 11, 2025, subject to customary closing conditions.
More on Lucid Diagnostics
- Lucid Diagnostics Inc. (LUCD) Investor Conference Call (Transcript)
- Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript
- Lucid Diagnostics announces proposed public offering of common stock
- Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG
- Seeking Alpha’s Quant Rating on Lucid Diagnostics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
